


Focus research 2022 RADOPT team
Focus research 2022 RADOPT team Metabolic shift & radioresistance The MSrGB (Metabolic Shift in radioresistance of Glioblastoma) project, which is coordinated by Prof. Elizabeth Moyal and accredited by the Fondation ARC (PGA) in 2022, aims to study the involvement...
Surface-guided radiotherapy overview: Technical aspects and clinical applications.
Surface-guided radiotherapy overview: Technical aspects and clinical applications. Breast, IGRT, Pelvis, Surface-guided radiotherapy, Image-guided radiotherapy, SGRT. Luc Simon Team RADOPT : Radiotherapy Optimising: from molecular signalling pathways to clinical...
Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma.
Encouraging phase 1 results of hypofractionated stereotactic re-irradiation in combination with Durvalumab in recurrent Glioblastoma. Durvalumab; deep learning; hypofractionated stereotactic re-irradiation; phase I clinical trial; recurrent glioblastoma; predictive...
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022 The Fonroga Foundation supports initiatives and achievements in the fields of culture and health in the Toulouse region. On 15 November 2022 it awarded several...